BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2014
View Archived Issues
OncoSec Medical and Plexxikon explore combination immunotherapy
Read More
AZD-1446 formulations tested for L-DOPA-induced dyskinesia
Read More
OMS-721 inhibits thrombus formation in ex vivo pathophysiologic system of aHUS
Read More
Preclinical data on effect of Nuvilex's pancreatic cancer treatment on ascites fluid formation
Read More
Canadian group discloses novel prodrugs of AR modulators
Read More
Duchenne muscular dystrophy is first target of Rosetta Genomics and Marina Biotech alliance
Read More
Cynapsus Therapeutics reports topline results from phase II trial of APL-130277
Read More
Diaxonhit initiates clinical study of Dx15 molecular test for thyroid cancer
Read More
First-in-human phase I promising results of afuresertib in recurrent ovarian cancer
Read More
ARMOR2 results: activity of galeterone in CRPC with AR-V7 variant
Read More
First demonstration of clinical activity of AG-120 a first-in-class inhibitor of mutated IDH1
Read More
New financings support Northwest Biotherapeutics' development of DCVax-L and DCVax-Direct
Read More
Veltuzumab receives FDA orphan drug status for pemphigus
Read More
AstraZeneca Canada confirms global lung cancer study of MED-14736
Read More
R-Pharm enters into an agreement with Bristol-Myers Squibb for Reyataz
Read More
BeneVir closes Series A investment
Read More
ALK seeks European approval for house dust mite sublingual allergy immunotherapy
Read More
Actelion Pharmaceuticals reports discovery of antibacterial compounds
Read More
Piramal Enterprises synthesizes novel TNF-alpha and IL-17 release inhibitors
Read More
Arena Pharmaceuticals reports development of Mas receptor modulators
Read More
Activity of novel PEGylated anti-IL-17A aptamer tested in models of rheumatoid arthritis
Read More
Gilead buys neglected disease priority review voucher from Knight Therapeutics
Read More
Evacetrapib improves cholesterol efflux in patients with dyslipidemia
Read More
Merz Pharma patents new 5-HT1A and 5-HT1B agonists
Read More
FDA approves opioid analgesic Hysingla ER
Read More
RSV F vaccine receives fast track to protect infants via maternal immunization
Read More